Evidence map›Paper›PMID 26350300›Full record

ArticleAmerican journal of hypertension2016

Aortic Fibrosis, Induced by High Salt Intake in the Absence of Hypertensive Response, is Reduced by a Monoclonal Antibody to Marinobufagenin.

Yulia N Grigorova, Ondrej Juhasz, Valentina Zernetkina, Kenneth W Fishbein, Edward G Lakatta, Olga V Fedorova, Alexei Y Bagrov

Open access · hybridAbstract read
In one paragraph

Article in American journal of hypertension, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Fli1 and Tissue Fibrosis in Various Diseases.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. The Pressure of Aging.The Medical clinics of North America · 2017
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yulia N GrigorovaNational Institute on Aging, NIH, Baltimore, Maryland, USA; Federal Almazov Medical Research Centre, and Sechenov Institute of Evolutionary Physiology and Biochemistry, St Petersburg, Russia.
Ondrej JuhaszNational Institute on Aging, NIH, Baltimore, Maryland, USA;
Valentina ZernetkinaNational Institute on Aging, NIH, Baltimore, Maryland, USA;
Kenneth W FishbeinNational Institute on Aging, NIH, Baltimore, Maryland, USA;
Edward G LakattaNational Institute on Aging, NIH, Baltimore, Maryland, USA;
Olga V FedorovaNational Institute on Aging, NIH, Baltimore, Maryland, USA;
Alexei Y BagrovNational Institute on Aging, NIH, Baltimore, Maryland, USA; bagrova@mail.nih.gov.
National Institute on Aging · US

Funding

Sodium pump ligands in blood pressure regulation and profibrotic signaling in hypertension, chronic kidney disease and aging in males and femalesZIAAG000609 · NIA · NATIONAL INSTITUTE ON AGING · PI FEDOROVA, OLGA V · 2009 to 2025
$17.3M
Marinobufagenin as a therapeutic targetZIAAG000869 · NIA · NATIONAL INSTITUTE ON AGING · PI LAKATTA, EDWARD · 2009 to 2025
$14.8M
Aging and interaction of natriuretic factors on renal and vascular sodium pumpZIAAG000868 · NIA · NATIONAL INSTITUTE ON AGING · PI BAGROV, ALEXEI · 2009 to 2015
$2.7M
Intramural NIH HHS
6 · The paper itself

Abstract

backgroundMarinobufagenin (MBG) is an endogenous Na/K-ATPase inhibitor, a natriuretic and a vasoconstrictor. MBG is implicated in salt-sensitive hypertension, cardiac hypertrophy, and initiate the pro-fibrotic signaling. Previously it was demonstrated that immunoneutralization of an endogenous MBG by 3E9 anti-MBG-antibody (mAb) in vivo lowered blood pressure (BP) and reversed cardiac fibrosis in salt-sensitive, and in partially nephrectomized rats. In the present study, we investigated whether mAb alleviates vascular remodeling induced in normotensive rats on high salt intake.

methodsWistar rats (5 months old) received normal (CTRL; n = 8) or high salt intake (2% NaCl in drinking water) for 4 weeks ( n = 16). Rats from the group on a high salt intake were administered vehicle (SALT; n = 8) or mAb (50 µg/kg) (SALT-AB; n = 8) during the last week of high salt diet. BP, erythrocyte Na/K-ATPase activity, levels of MBG in plasma and 24-hour urine, and sensitivity of aortic explants to the vasorelaxant effect of sodium nitroprusside (SNP) were measured. Aortic collagen abundance was determined immunohistochemically.

resultsIn SALT vs. CTRL, heightened levels of MBG were associated with inhibition of erythrocyte Na/K-ATPase in the absence of BP changes. High salt intake was accompanied by a 2.5-fold increase in aortic collagen abundance and by a reduction of sensitivity of aortic explants to the vasorelaxant effect of SNP following endothelin-1-induced constriction. In the SALT-AB group, all NaCl-mediated effects were reversed by immunoneutralization of MBG.

conclusionsHigh salt intake in young normotensive rats can induce vascular fibrosis via pressure-independent/MBG-dependent mechanisms, and this remodeling is reduced by immunoneutralization of MBG.

Indexed as

AnimalsAntibodies, MonoclonalAortaAortic DiseasesBufanolidesCollagenDisease Models, AnimalFibrosisMaleRats, WistarSodium, DietaryVasodilationVasodilator AgentsAntibodies, MonoclonalBufanolidesCollagenmarinobufageninSodium, DietaryVasodilator Agentsblood pressurehigh salt intakehypertentionmarinobu fageninmonoclonal antibodyNa/K-ATPasevascular fibrosis.

Identifiers

PMID26350300
PMCPMC5014083
OpenAlexW2335887350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.